These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8442669)

  • 1. Morphometric analysis of benign and malignant adrenal pheochromocytomas.
    Hoffman K; Gil J; Barba J; Liu Z; Pertsemlidis D; Kaneko M; Unger P
    Arch Pathol Lab Med; 1993 Mar; 117(3):244-7. PubMed ID: 8442669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
    Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
    Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
    Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant pheochromocytoma. A case report and comments on a rare pathology].
    Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S
    Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of telomerase activity in malignant pheochromocytoma.
    Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
    Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
    APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of differential diagnosis for benign and malignant pheochromocytomas.
    Gao B; Kong F; Xu Z
    Int J Urol; 2008 Sep; 15(9):771-7. PubMed ID: 18651863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.
    Nagura S; Katoh R; Kawaoi A; Kobayashi M; Obara T; Omata K
    Mod Pathol; 1999 Dec; 12(12):1107-11. PubMed ID: 10619262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical study of pheochromocytomas.
    Lloyd RV; Shapiro B; Sisson JC; Kalff V; Thompson NW; Beierwaltes WA
    Arch Pathol Lab Med; 1984 Jul; 108(7):541-4. PubMed ID: 6203498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
    Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
    Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy in pheochromocytomas.
    Salmenkivi K; Heikkilä P; Haglund C; Arola J
    APMIS; 2004 Sep; 112(9):551-9. PubMed ID: 15601303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of Pheochromocytoma of the Adrenal Gland Scaled Score (Pass score) tests to separate benign from malignant neoplasms.
    Mlika M; Kourda N; Zorgati MM; Bahri S; Ben Ammar S; Zermani R
    Tunis Med; 2013 Mar; 91(3):209-15. PubMed ID: 23588637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
    Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
    Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas.
    Gao B; Meng F; Bian W; Chen J; Zhao H; Ma G; Shi B; Zhang J; Liu Y; Xu Z
    Urology; 2006 Aug; 68(2):282-6. PubMed ID: 16904437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear DNA content, proliferation index and nuclear size determination in normal and tumoral adrenal tissues, pheochromocytomas and metastases.
    Remmelink M; Salmon I; Pasteels JL; Ardichvili D; Kiss R
    Acta Cytol; 1995; 39(3):416-22. PubMed ID: 7762326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.
    Unger P; Hoffman K; Pertsemlidis D; Thung S; Wolfe D; Kaneko M
    Arch Pathol Lab Med; 1991 May; 115(5):484-7. PubMed ID: 1673596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].
    Feng C; Li HZ; Yan WG; Gao JG; Xu WF; Luo YF; Cao JL
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(24):1697-700. PubMed ID: 18476530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative secretory profiles of benign and malignant pheochromocytomas].
    Proye C; Racadot-Leroy N; Vix M; Vermesse B; Carnaille B
    Ann Chir; 1994; 48(5):430-4. PubMed ID: 7810975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.